Industry stronger in Brazilian policy body:
This article was originally published in Clinica
Executive Summary
Brazil's national healthcare council (CNS, Conselho Nacional de Saude) has, for the first time in its 70-year history, elected an industry representative as chairman. Until now, the position was automatically filled by the health minister. The appointment of pharmacist Francisco Batista Junior is seen, by the government's own admission, as a key step in the strengthening and democratisation of the CNS, which has a significant influence on healthcare policy-making, nationally. The healthcare manufacturing and service provision sectors are each represented by six members of the 72-seat council.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.